ALLO vs COF · rev $22.0K vs P/E 62, rev $53.43B
Allogene Therapeutics Inc (ALLO) versus Capital One Financial Corporation (COF) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
ALLO currently screens at market cap $258.1M. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Not investment advice. Open the ALLO and COF stock pages for the full models.
Not investment advice.